http://orcid.org/0000-0002-6842-1720
References
- Chen Y, Yang X, Nguyen Pham V, et al. Heart rate control is associated with the reduced cardiovascular events in Asian patients with coronary artery disease treated with bisoprolol (BISO-CAD): results from a multi-national, real-world experience. Curr Med Res Opin 2017;34(2):1-27
- Bauters C, Lemesle G, Meurice T, et al. Prognostic impact of sz-blocker use in patients with stable coronary artery disease. Heart Br Card Soc 2014;100:1757-61
- Steg PG, De Silva R. Beta-blockers in asymptomatic coronary artery disease: no benefit or no evidence? J Am Coll Cardiol 2014;64:253-5
- Stępińska J, Marona M, Greenlaw N, et al. Heart rate and the use of beta blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry. Kardiol Pol 2014;72:1156-64
- Tendera M, Fox K, Ferrari R, et al. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. Int J Cardiol 2014;176:119-24
- Bangalore S, Steg G, Deedwania P, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012;308:1340-9
- Goldberger JJ, Bonow RO, Cuffe M, et al. beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing. Am Heart J 2010;160:435-42.e1
- Chen Y, Yang X, Huang S, et al. Occurrence of composite cardiac endpoints with change in resting heart rate among Chinese patients with coronary artery disease: Chinese cohort from the real-world BISO-CAD study. Curr Med Res Opin 2018;25:1-6
- Cooney MT, Vartiainen E, Laatikainen T, et al. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010;159:612-19
- Lang CC, Gupta S, Kalra P, et al. Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease. Atherosclerosis 2010;212:1-8
- Khan H, Kunutsor S, Kalogeropoulos AP, et al. Resting heart rate and risk of incident heart failure: three prospective cohort studies and a systematic meta-analysis. J Am Heart Assoc 2015;4:e001364
- Saraiva F, Antonio N, Lourenco C, et al. Heart rate and prognosis in acute coronary syndromes. Rev Port Cardiol 2010;29:1101-19
- Lonn EM, Rambihar S, Gao P, et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol Off J Ger Card Soc 2014;103:149-59
- Wang SL, Wang CL, Wang PL, et al. Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Exp Biol Med 2016;241:478-84
- Squire IB, Barnett DB. The rational use of beta-adrenoceptor blockers in the treatment of heart failure. The changing face of an old therapy. Br J Clin Pharmacol 2000;49:1-9
- Goldberger JJ, Bonow RO, Cuffe M, et al.; OBTAIN Investigators. Effect of beta-blocker dose on survival after acute myocardial infarction. J Am Coll Cardiol 2015;66:1431-41